baber/WOPTO huggingface dataset:
Patent EP-3139993-A1 (EP)
Title: Verbindungseinrichtung für einen katheter, insbesondere einen peripheren venenkatheter (iii)
Inventor: REICHARDT ANDRÉ
IPC: A61M5/165
Filed: 2015-04-30
Abstract: Eine Verbindungseinrichtung für einen Katheter, insbesondere einen peripheren Venenkatheter, umfassend: a) einen einen Hauptkörper-Infusionskanal (2) aufweisenden Hauptkörper (1) mit einem sterilisierend wirkenden und zumindest einen Teil des Hauptkörper-Infusionskanals (2) bildenden Durchflusselement (3, 103, 203) und einem Koppelelement (6), wobei der Hauptkörper (1) einstückig ist, und b) einen einen Anschlusskörper-Infusionskanal (7) aufweisenden Anschlusskörper (8), wobei der Anschlusskörper (8) und das Koppelelement (6) Mittel zur lösbaren Fixierung des Anschlusskörpers (8) am Koppelelement (6) aufweisen, kennzeichnet sich dadurch, dass c) der Hauptkörper (1) sterilisierend wirkendes Massivmaterial umfasst, wobei das Massivmaterial zumindest an zum Kontakt mit Infusionsflüssigkeit vorgesehenen Wänden unbeschichtet ist und d) das Massivmaterial eine Matrix aus mindestens einem ersten Material umfasst, wobei in die Matrix mindestens ein sterilisierend wirkendes weiteres Material eingearbeitet ist.
Patent EP-3161781-A1 (EP)
Inventor: GIRADO JAVIER IGNACIO
IPC: G06T1/20
Filed: 2015-06-25
Abstract: A texture pipe of a graphics processing unit (GPU) may receive a texture data. The texture pipe may perform a block-based operation on the texture data, wherein the texture data comprises one or more blocks of texels. Shader processors of the GPU may process graphics data concurrently with the texture pipe performing the block-based operation. The texture pipe may output a result of performing the block-based operation on the one or more texture data.
Patent EP-3161064-A1 (EP)
Inventor: TLUSTOS GIORGIO
IPC: C08L33/12
Filed: 2015-06-19
Abstract: Polymethyl methacrylate cast sheet article that comprises one or more anti- scratch additives selected from among the polydimethylsiloxanes and their derivatives.
Patent EP-3100712-A1 (EP)
Inventor: HOKII YUSUKE
IPC: A61K6/884
Filed: 2015-01-30
Abstract: Provided is a filler for dental glass ionomer cements, the filler to a surface of which a compound(s) having a carboxyl group(s) is/are bound via a silicon atom, for the purpose of providing: a filler suitable for dental glass ionomer cements that can provide a hardened cement having a high strength by being mixed with a dental glass ionomer cement composition, the filler that can be easily manufactured from a general inorganic powder as a raw material; and a manufacturing method of the filler for dental glass ionomer cements. The manufacturing method includes binding a carboxylic acid having an unsaturated double bond(s) exclusive of a (meth) acrylate compound to an inorganic powder whose surface is treated with a silane coupling agent having an unsaturated double bond(s).
Patent EP-3099368-A1 (EP)
Inventor: CHAO TAR TOONG VICTOR
IPC: A61M25/01
Filed: 2015-01-30
Abstract: A cannula includes a first segment configured to reside entirely within a vessel. The first segment includes a proximal exit opening disposed nearer to the heart, and multiple fenestrations disposed distally away from the proximal exit opening near a cannulation site. The fenestrations in combination with the proximal exit opening enable simultaneous perfusion of blood into the cannulated vessel along proximal and distal directions. During a medical procedure, blood introduced into a vessel (e.g., the femoral artery) by way of the cannula can exit the cannula in a manner that provides concurrent blood flow in a first set of directions proximally towards the heart and a second set of directions distally away from the heart. Radially displaceable anchoring elements positionable adjacent to the vessel's superficial wall aid retention of the first segment in the vessel. The fenestrations and/or anchoring elements can be arranged obliquely around portions of the cannula's circumference.
Patent EP-3104010-A1 (EP)
Inventor: ISHII TAKUYA
IPC: F04C15/00
Filed: 2015-01-30
Abstract: Provided is a transverse internal gear pump that can be manufactured at low cost, and also has a high safety factor in terms of functionality. This transverse internal gear pump 1 has a trochoid 4, in which an inner rotor 3 having a plurality of outer teeth is rotatably accommodated within an outer rotor 2 having a plurality of inner teeth, the inner rotor being rotatably accommodated within the outer rotor in an eccentric state and with the outer teeth and the inner teeth meshing, and in which an intake-side volume chamber for taking in a liquid and an ejection-side volume chamber for ejecting liquid taken into the intake-side volume chamber are formed between the inner teeth and the outer teeth; a liquid intake nozzle 9 extending in a non-perpendicular direction with respect to the trochoid rotation surfaces and having a distal end immersed in a liquid reservoir 18; a pump casing 5 in which a recessed portion 5a for accommodating the trochoid is formed; and a pump cover 6 for closing off the recessed portion. An intake cover 8 that has the liquid intake nozzle 9 is secured to the pump casing 5, and the liquid intake nozzle 9 and the intake cover 8 are integrally molded by the injection molding of a resin composition.
Patent EP-3174358-A1 (EP)
Inventor: CHEN JUN
IPC: H04W12/04
Filed: 2015-02-12
Abstract: A method and apparatus for communicating and connecting with an intelligent terminal are disclosed. A wireless peripheral in the embodiments of the present invention acquires wireless access point information corresponding to an intelligent terminal prompted by the intelligent terminal with which communication connection needs to be performed; and according to the acquired wireless access point information of the intelligent terminal, performs the communication connection with the intelligent terminal by connecting a wireless access point corresponding to the wireless access point information. The embodiments of the present invention simplifies the wireless connection configuration operations required to be performed when wireless transmission is utilized in the related art, which improves the usability of the wireless network peripheral wirelessly communicating and connecting with the intelligent terminal.
Patent EP-3178216-A1 (EP)
Inventor: JAIN NAVENDU
IPC: H04L29/08
Filed: 2015-08-04
Abstract: Described herein are various technologies pertaining to identification of inbound and outbound network and application attacks with respect to a data center. Commodity servers are used to monitor ingress and egress traffic flows, and anomalies are detected in the traffic flows. Responsive to detecting an anomaly, a mitigation strategy is executed to mitigate damage caused by a cyber-attack.
Patent EP-3171890-A1 (EP)
Inventor: MATTSSON LARS
IPC: A61K39/35
Filed: 2015-07-20
Abstract: The invention relates to a novel horse allergen consisting of a heterodimeric protein having a first peptide chain and a second peptide chain together having an overall sequence identity of at least 70 % with the combined sequences of SEQ ID NO:3 and SEQ ID NO: 4, as well as a single chain protein having an overall sequence identity of at least 70%, such as 75%, 80%, 85%, 90%, 95%, or 98%, with the combined amino acid sequences according to SEQ ID NO: 3 and SEQ ID NO: 4.The invention further relates to the use of the protein in methods of diagnosis and therapy of Type I allergy, and kits and compositions for use in such methods.
Patent EP-3112867-A1 (EP)
Inventor: COIMBRA RONEY SANTOS
IPC: G01N33/68
Filed: 2015-02-24
Abstract: The instant invention relates to a qualitative predictive method, to a method, use and kit applied to the early differential diagnosis of the most prevalent forms of bacterial and viral meningitis, enabling to detect and distinguish the different forms of meningitis. The invention uses a qualitative predictive method based on combined detection and sequential analysis of the presence/absence of at least three out of four specific biomarkers.
Patent EP-3112061-A1 (EP)
Title: Main shaft device
Inventor: OGURI SHOICHIRO
IPC: F16C19/54
Filed: 2015-02-26
Abstract: A cooling passage (40) through which a cooling medium can flow is formed between the inner peripheral surface of a rear housing (33), and the outer peripheral surface of a bearing sleeve (16) having a free-side bearing inserted therein. The cooling passage (40) is formed in the outer peripheral surface of the bearing sleeve (16), and is provided with: a first annular groove (41A) provided to one-end side of the sleeve in the axial direction; a second annular groove (41B) provided to another-end side of the sleeve in the axial direction; and a single helical groove (47) which has one end thereof connected to the first annular groove, and another end thereof connected to the second annular groove. The cooling medium is supplied to the first annular groove, flows through the cooling passage, and is discharged from the second annular groove.
Patent EP-3120919-A1 (EP)
Inventor: WATANABE KEISHI
IPC: B01D63/00
Filed: 2015-03-10
Abstract: A membrane casing that watertightly houses a membrane element 2 for filtering raw water includes a tubular casing main body 40, a lid body 50, and a pressing mechanism 60 and 70. The casing main body 40 houses a membrane element 2. The lid body 50 fits an opening end of the casing main body 40 and is movable in the axial direction of the casing main body 40 while maintaining the attitude and while securing watertightness with the casing main body 40. The pressing mechanism 60 and 70 presses the lid body 50 to press and hold the membrane element 2 housed in the casing main body 40. The membrane casing has a simple configuration capable of watertightly securing using a predetermined pressing force by accommodating variations in size of the membrane element, even if the membrane casing cannot be formed into a cylindrical shape.
Patent EP-3120769-A1 (EP)
Inventor: SHIGENAGA NOBUAKI
IPC: A61B5/1455
Filed: 2015-02-27
Abstract: In order to provide a biological information measurement device which ensures sturdiness, less easily falls off a finger and less easily inhibits a blood flow by measurement performed over an extended period of time, there is provided a biological information measurement device which acquires biological information of a subject body by receiving, in a light receiving unit, light emitted from a light source unit while a finger of the subject body is inserted into space between the light source unit and the light receiving unit, the device including a body, a probe unit, and a connection portion electrically connecting the body and the probe unit. Here, the body includes a casing in which a battery and an electrical circuit are incorporated, and a first fitting portion which is attached to the casing and worn on a first fitted portion including a portion of at least one of a proximal phalanx and a middle phalanx of the finger. Moreover, the probe unit includes the light source unit and the light receiving unit, as well as a second fitting portion that is worn on a second fitted portion including a distal phalanx of the finger.
Patent EP-3123090-A1 (EP)
Inventor: THOME BRIAN M
IPC: F26B5/06
Filed: 2015-03-24
Abstract: The present invention provides, among other things, pre-tyophilization formulations, reconstituted formulations, and lyophilate powder compositions comprising a Factor IX (FIX) polypeptide. The present invention also provides lyophilization methods for producing lyophilate powder comprising a FIX polypeptide.The present invention is directed to a pre-tyophilization formulation comprising: (a) a Factor IX (FIX) polypeptide having FIX coagulation activity; (b) a buffering agent; (c) a stabilizing agent; (d) a bulking agent; and (e) a surfactant, wherein the formulation has a fill volume of less than about 5 mL,and wherein each of (a) - (e) are at an amount per vial (mg/vial) sufficient to allow (1) improved stability of the FIX polypeptide when lyophilized.
Patent EP-3201346-A1 (EP)
Inventor: STUFANO PAOLO
IPC: C02F3/12
Filed: 2015-09-22
Abstract: L'invention concerne un composite à matrice polymère d'origine biologique provenant d'un unique courant d'eaux usées et un procédé de production de ces composites à matrice polymère d'origine biologique à partir d'un unique courant d'eaux usées. Le procédé selon l'invention permet la production de la matrice polymère d'origine biologique ainsi que de l'additif, les principaux constituants du composite, en même temps, à partir d'une unique source de courant d'eaux usées. Dans un mode de réalisation préféré, la présente invention s'applique, sans s'y limiter, à la production d'un composite d'un polyhydroxyalcanoate (PHA) à partir d'un unique courant d'eaux usées issues du broyage des olives (OMW). Une application de ces composites est représentée, sans s'y limiter, par une utilisation en tant que matériaux pour produire des produits agricoles.
Patent EP-3207237-A1 (EP)
Inventor: CHARRIER JEAN LOUIS
IPC: F02D41/00
Filed: 2015-09-14
Abstract: L'invention concerne un procédé de commande d'un moteur à combustion de véhicule automobile comportant une étape consistant à évaluer si la consigne de couple (1 ) est inférieure à un couple seuil (Ts) distinct du couple minimal atteignable avec le nombre de cylindres actifs actuel (3) et distinct du couple maximal atteignable avec un cylindre actif en moins (5).
Patent EP-3126890-A1 (EP)
Inventor: NIELSEN LARS KRISTIAN
IPC: G02B6/38
Filed: 2015-03-27
Abstract: A cable assembly includes a distribution cable, a tether cable, and a network access point (NAP) assembly having a cavity defined therein. The distribution cable includes optical fibers and the tether cable includes an optical fiber. The optical fiber of the tether cable is tightly constrained within the tether cable and portion thereof extends from the tether cable into the cavity of the NAP assembly and is spliced to a portion of one of the optical fibers of the distribution cable extending into the cavity of the NAP assembly from a side of the distribution cable. The splice is positioned in the cavity. Tight constraint of the optical fiber of the tether cable within the tether cable limits transmission of fiber movement to the portion of the optical fiber of the tether cable extending into the cavity of the NAP assembly, thereby protecting the splice.
Patent EP-3130874-A1 (EP)
Inventor: TOMIOKA YUSUKE
IPC: F28F9/013
Filed: 2015-03-12
Abstract: A gas cooler 10 includes a pair of seal plates 42, 42 and a pair of first support ribs 26, 26. The individual seal plate 42 has a stepped surface 42A which extends in a direction that a cooling portion 35 is inserted into a casing 21. The individual first support rib 26 supports the stepped surface 42A. With the configuration where the stepped surface 42A is supported by the first support rib 26, the inside of the casing 21 is partitioned into an upstream-side space 213 communicated with an introducing port 27 and a downstream-side space 214 communicated with a discharging port 31.
Patent EP-3133896-A1 (EP)
Inventor: FUKUTA NORIYOSHI
IPC: H04W16/14
Filed: 2015-04-07
Abstract: An LTE system includes an eNB 200-2 configured to support D2D communication which is one of LTE communication schemes and in which communication is directly performed between proximal devices, and an eNB 200-1 included in an LTE network. A communication control method includes: a step S11 of requesting, by the eNB 200-2, an allocation of a D2D communication resource to the eNB 200-1; a step S12 of allocating, by the eNB 200-1, on the basis of the request from the eNB 200-2, the D2D communication resource from a specific frequency band shared by a plurality of mobile network operators or a plurality of communication systems, to the eNB 200-2; and a step S16 of performing, by the eNB 200-2, the D2D communication by using the D2D communication resource allocated from the eNB 200-1.
Patent EP-3131550-A1 (EP)
Inventor: TROWE TORSTEN BERNHARD
IPC: C07D487/04
Filed: 2015-04-15
Abstract: La présente invention concerne des méthodes de traitement ou de prévention du cancer, consistant à administrer une quantité efficace d'un inhibiteur de la kinase TOR et une quantité efficace d'un principe actif à un patient ayant un cancer. Le deuxième principe actif de la méthode de traitement est un inhibiteur de histone désacétylase sélectionné parmi Belinostat, MS-275 et Romidepsine, administré en combinaison avec l'inhibiteur de la kinase TOR.
Patent EP-3210330-A1 (EP)
Inventor: DAMNJANOVIC JELENA
IPC: H04L5/00
Filed: 2015-09-30
Abstract: L'invention concerne des procédés, des systèmes, et des dispositifs de communications sans fil. Une station de base peut utiliser une configuration de multiplexage basée sur des considérations de latence et d'efficacité. La station de base peut transmettre une attribution de ressources, un signal indiquant la longueur d'un intervalle de temps de transmission (TTI) de liaison descendante (DL) et un signal indiquant la longueur d'un TTI de liaison montante (UL) suivant, à un ou plusieurs équipements d'utilisateurs (UE). La station de base peut sélectionner de façon dynamique une nouvelle configuration de multiplexage en définissant, par exemple, la longueur d'un TTI UL à zéro ou en attribuant à une pluralité d'UE des ressources dans le même TTI DL. La latence peut également être réduite en employant une réaction par blocs, une réaction de requête automatique de répétition hybride (HARQ) par exemple. Un UE peut déterminer et transmettre une réaction HARQ pour chaque bloc de transport (TB) d'un ensemble de TB, la réaction pouvant être basée sur la durée d'un TTI de liaison descendante.
Patent EP-3215728-A1 (EP)
Inventor: PACILLY CHRISTOPHE
IPC: F02D41/14
Filed: 2015-10-20
Abstract: The invention relates to a method for estimating the air mass contained within the combustion chamber of a variable-timing heat-engine cylinder, which includes the steps of measuring the current position of the variable-timing actuators for each of the valves of the cylinder, predicting the time at which the exhaust valve closes (FE) and the times at which the intake valve opens and closes (OA, FA), in accordance with the current positions measured, and estimating the air mass (P masse air) estimated from the predicted times, in which, during the prediction step, the current position of each of said variable-timing actuators is corrected in accordance with the set position (Pos VTT cons sat filt) of each of the actuators.
Patent EP-3147321-A1 (EP)
Inventor: SAIKI AYA
IPC: C08K5/18
Filed: 2015-05-22
Abstract: Provided is a rubber composition that has better weather resistance than conventional rubber compositions and can inhibit surface discoloration of a rubber article. The rubber composition contains at least one rubber component selected from natural rubber and diene-based synthetic rubbers and, blended therewith, at least one amine compound represented by formula (I) shown below. In formula (I), R 1  and R 2  each represent, independently of one another, an alkyl group having a carbon number of 1-10, an aralkyl group, or a phenyl group, and A represents an alkylene group having a carbon number of 6-30 that may include an interposed phenylene group.
Patent EP-3146566-A1 (EP)
Inventor: PANDEY SUMEET C
IPC: H01L27/115
Filed: 2015-04-23
Abstract: A ferroelectric memory cell comprises a ferroelectric crystalline material having a polar and chiral crystal structure without inversion symmetry through an inversion center. The ferroelectric crystalline material does not consist essentially of an oxide of at least one of hafnium (Hf) and zirconium (Zr).
Patent EP-3212224-A1 (EP)
Inventor: GEALL ANDREW
IPC: A61K39/00
Filed: 2015-10-28
Abstract: La présente invention concerne des méthodes basées sur des molécules d'acides nucléiques exogènes, telles que de l'ARN, qui codent pour un anticorps ou un fragment de liaison à l'antigène d'un anticorps, et éventuellement codent pour un facteur de modulation cellulaire et/ou un facteur de potentialisation. Le facteur cellulaire de modulation est un facteur qui permet d'obtenir une expression accrue de l'anticorps et/ou d'un fragment de liaison à l'antigène. Le facteur de potentialisation est un facteur qui fournit l'anticorps effecteur souhaité ou offre d'autres propriétés. Les molécules d'acide nucléique exogènes peuvent être de l'ADN ou de l'ARN, tel que de l'ARNm (y compris de l'ARN auto-réplicatif et de l'ARN non auto-réplicatif) L'invention concerne également une méthode d'administration des molécules d'acide nucléique exogènes à un patient dans le but d'obtenir chez le patient la production de l'anticorps ou du fragment de liaison à l'antigène codés afin de fournir, par exemple, une immunité passive prophylactique ou thérapeutique.
Patent EP-3224202-A1 (EP)
Title: Procédé pour augmenter la taille de particule d'octamolybdate ammonium (aom)
Inventor: JARVIS ANTHONY
IPC: C01G39/00
Filed: 2015-11-24
Abstract: L'invention concerne un procédé d'augmentation de la taille de particule d'une poudre de pigment de type octamolybdate d'ammonium (AOM).
Patent EP-3229873-A1 (EP)
Inventor: MARSH WILLIAM GEOFFREY ARTHUR
IPC: A61M5/315
Filed: 2015-12-08
Abstract: La présente invention se rapporte à un mécanisme d'entraînement destiné à être utilisé dans un dispositif d'administration de médicament comportant une cartouche (140), le mécanisme comprenant un élément (30) de base, une tige (120) de piston dentée mobile à partir d'une première position rétractée correspondant à une cartouche pleine vers une seconde position déployée correspondant à une cartouche vide, la tige (120) de piston étant guidée à l'intérieur de la partie (30) de base et mobile par rapport à celle-ci et un engrenage (110) d'entraînement ayant un pignon (114), qui est maintenu en rotation dans l'élément (30) de base et en prise par engrènement avec la tige (120) de piston dentée, la tige (120) de piston dentée comprenant de multiples pièces (121) de tige rigide qui sont reliées par des charnières (122) et un ressort (130) d'entraînement, qui est fixé à l'élément (30) de base à une extrémité et fixé à l'engrenage (110) d'entraînement à une autre extrémité et qui exerce une force ou un couple sur l'engrenage (110) d'entraînement destiné à faire tourner l'engrenage (110) d'entraînement par rapport à l'élément (30) de base, ladite rotation entraînant un mouvement de la tige (120) de piston dentée. Le ressort (130) d'entraînement est chargé pendant la production ou l'assemblage, l'énergie stockée dans le ressort (130) d'entraînement étant suffisante pour déplacer la tige (120) de piston à partir de la première vers la seconde position. L'invention concerne également un dispositif d'administration de médicament.
Patent EP-3160504-A1 (EP)
Inventor: KUMAR SANTHOSH V R
IPC: A61K39/00
Filed: 2015-06-23
Abstract: Severe glomerulonephritis involves cell necrosis as well as NETosis, programmed neutrophil death leading to expulsion of nuclear chromatin and neutrophil extracellular traps (NETs). Histones released by neutrophils undergoing NETosis killed glomerular endothelial cells, podocytes, and parietal epithelial cells. This was prevented by histone-neutralizing agents anti-histone IgG, activated protein C and heparin. Histone toxicity on glomeruli was TLR2/4-dependent. Anti-GBM glomerulonephritis involved NET formation and vascular necrosis. Pre-emptive anti-histone IgG administration significantly reduced all aspects of glomerulonephritis, including vascular necrosis, podocyte loss, albuminuria, cytokine induction, recruitment and activation of glomerular leukocytes and glomerular crescent formation. Subjects with established glomerulonephritis treated with anti-histone IgG, recombinant activated protein C, or heparin all abrogated severe glomerulonephritis suggesting that histone-mediated glomerular pathology is a subsequent, not initial event in necrotizing glomerulonephritis. Neutralizing extracellular histones is therapeutic in severe experimental glomerulonephritis.